Open house drug discount contracts for Dolutegravir/Rilpivirine in Germany.
The procurement concerns the conclusion of drug discount contracts for the active ingredient combination Dolutegravir and Rilpivirine (ATC code J05AR21) under an open-house model. The buyer is a German statutory health insurance association, serving the insured population. No specific qualifications or set-asides are mentioned; the open-house procedure implies any qualified pharmaceutical supplier can participate. The scale is not specified but typical for such contracts is multi-year with significant volume.